当前位置：
X-MOL 学术
›
Expert Rev. Pharmacoecon. Outcomes Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Willingness to pay for cancer prevention versus treatment in China: implications for cost-effectiveness threshold
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2024-01-18 , DOI: 10.1080/14737167.2023.2262141 Zixuan Zhao 1 , Yi Yang 2 , Weijia Wu 2 , Hengjin Dong 2
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2024-01-18 , DOI: 10.1080/14737167.2023.2262141 Zixuan Zhao 1 , Yi Yang 2 , Weijia Wu 2 , Hengjin Dong 2
Affiliation
Empirical support for the appropriate cost-effectiveness threshold (CET) in China remains sparse.This study aimed to estimate the willingness to pay (WTP) for cancer prevention and treatment from t...
更新日期：2024-01-20
京公网安备 11010802027423号